Skip to content

Drug interactions

Fedratinib + Montelukast

Severity: Minor

Fedratinib and Montelukast: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fedratinib inhibits CYP3A4, CYP2C19 and CYP2D6, but montelukast depends mainly on CYP2C8. Any increase in montelukast levels is expected to be small and montelukast has a wide safety margin.

What this interaction means in plain words

Fedratinib and Montelukast have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Fedratinib belongs to Oncology; Montelukast belongs to Respiratory.

Evidence level: Low

Why it happens

Fedratinib inhibition of CYP3A4 may slightly reduce a minor montelukast clearance route.

What to do

No dose adjustment is needed. Monitor for montelukast adverse effects such as headache or mood changes.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fedratinib and Montelukast, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Fedratinib with Montelukast?

MediHelp rates the interaction as minor. Fedratinib and Montelukast have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Fedratinib inhibits CYP3A4, CYP2C19 and CYP2D6, but montelukast depends mainly on CYP2C8. Any increase in montelukast levels is expected to be small and montelukast has a wide safety margin.

How serious is the interaction between Fedratinib and Montelukast?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is needed. Monitor for montelukast adverse effects such as headache or mood changes.

What other medicines interact with Montelukast?

MediHelp also lists interactions of Montelukast with, for example, Apalutamide, Carbamazepine, Deferasirox. The full list is on the Montelukast page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in